Regeneron Pharmaceuticals, Inc.
CHO integration sites and uses thereof

Last updated:

Abstract:

Expression-enhancing nucleotide sequences for eukaryotic expressions systems are provided that allow for enhanced and stable expression of recombinant proteins in eukaryotic cells. Genomic integration sites providing enhanced expression and methods of use thereof are provided for expression of a gene of interest in a eukaryotic cell. Chromosomal loci, sequences, and vectors are provided for enhanced and stable expression of genes in eukaryotic cells.

Status:
Grant
Type:

Utility

Filling date:

12 Feb 2021

Issue date:

8 Mar 2022